MedPath

Doxel

Brand Name: Doxel

Generic Name: Docetaxel

Active
Registration Number

DR-XY48248

Dosage Form

Concentrate for Solution for IV Infusion

Issuance Date

August 2, 2022

Expiry Date

August 2, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength20 mg/mL
Packaging2 mL-capacity USP Type I glass vial with grey chlorobutyl rubber stopper and green aluminum flip-off seal (Box of 1 vial x 1 mL); 6 mL-capacity USP Type I glass vial with grey chlorobutyl rubber stopper and orange aluminum flip-off seal (Box of 1 vial x.4 mL)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antineoplastic Agent
A
Application
Initial
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

DocetaxelActive
Monograph: Docetaxel

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform